U.S. Medical Equipment Stock News

Artificial intelligence sits at the center of many market conversations right now, from chip makers and cloud providers to software platforms building on tools like ChatGPT. While global growth signals are mixed, with manufacturing and inflation trends varying across regions, AI remains a core theme many investors are watching. The AI Stocks screener focuses on companies that are directly exposed to this shift in semiconductors, software, LLMs and cloud infrastructure. In this article, you...

Bunge Global SA recently reported past second-quarter 2026 results showing sales of US$24,041 million and net income of US$678 million, with higher basic and diluted earnings per share from continuing operations than a year earlier. The continued execution of its long-running US$2.70 billion share repurchase program, alongside the Viterra integration, highlights management’s focus on capital returns and operational consolidation. We’ll now examine how Bunge Global’s stronger quarterly...

DT Midstream, Inc. reported past second-quarter 2026 results with sales of US$343 million and net income of US$112 million, alongside higher earnings per share versus a year earlier. For the first half of 2026, the company delivered higher year-on-year revenue and net income and its board declared a US$0.88 per-share dividend payable on October 15, 2026, reinforcing its income-focused profile. Next, we’ll examine how DT Midstream’s higher first-half 2026 earnings and confirmed US$0.88...

In late July 2026, Vertex released extensive research showing that global enterprises are grappling with rising indirect tax audit complexity, fragmented systems, and heavy manual effort to reach audit readiness across jurisdictions. The study introduces concepts like “Defensibility Drift,” “CompOps Drag,” and the “Compliance Confidence Gap,” highlighting how weak integration and proof capabilities can cause enterprises to leave millions in potential tax-related benefits unrealized each...

In July 2026, General Motors reported second-quarter revenue of US$48,026 million and net income of US$1,305 million, affirmed a US$0.18 quarterly dividend payable on September 17, 2026, completed a US$14.47 billion share buyback covering 24.61% of its stock, and filed a US$2.05 billion shelf registration for 27,000,000 ESOP-related shares. A key development for investors is Chevrolet’s launch of the Grand Sport X hybrid Corvette, which ties high-performance branding directly to GM’s...

In July 2026, Southern Copper Corporation reported that second-quarter sales rose to US$4,289 million and net income to US$1,670 million, and its board approved a US$1.10 per-share cash dividend payable on August 27, 2026, to shareholders of record on August 11, 2026. Despite lower mined volumes for copper, molybdenum and zinc versus a year earlier, Southern Copper’s earnings and dividend growth highlight how pricing, costs and product mix can materially influence results beyond headline...

Belden Inc. recently reported its second-quarter 2026 results, with sales of US$750.16 million and diluted EPS from continuing operations of US$1.74, and issued third-quarter guidance calling for revenues of US$950–US$970 million and GAAP EPS of US$0.69–US$0.84. The company also highlighted growing demand tied to data-center and AI infrastructure and closed its RUCKUS Networks acquisition, which it expects to immediately contribute to revenue, EPS, and EBITDA. We’ll now examine how this...

After a 42.3% return over the past year, Prologis now sits in a less clear-cut spot on price. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock trades at a premium, while market-based multiples look broadly in line. Prologis has delivered a 42.3% return over the last 12 months, which puts extra focus on whether recent gains have already baked in much of the good news. The raised US$18.7b bid for Segro can support a larger logistics portfolio and long term cash flow,...

Why Apogee Therapeutics Stock Is On Investors’ Radar Apogee Therapeutics (APGE) recently attracted attention after its strong past 3 months return, which contrasts with relatively flat moves over the past week and month. Investors are weighing that performance against its current clinical stage profile. See our latest analysis for Apogee Therapeutics. At a latest share price of US$134.09, Apogee Therapeutics has seen share price momentum cool in the very short term. However, its 90 day share...

The potential US$400b merger talks between AstraZeneca and Bristol Myers Squibb have thrown a fresh spotlight on the ecosystem that sits behind every big pharma deal. Advisory, legal, and M&A service providers that focus on healthcare can feel the ripple effects of this kind of headline, even while AstraZeneca shares themselves react sharply, with a drop of over 7% on the news. This article looks at how this development might influence deal related activity and what that could mean for...

IDACORP, Inc. recently reported past second-quarter 2026 results showing higher sales of US$468.67 million and net income of US$102.58 million, alongside increased earnings per share versus the prior year period. At the same time, the company raised the lower end of its full-year 2026 earnings guidance range, signaling management’s confidence while planning to use less than US$15 million of additional tax credits available under Idaho’s regulatory mechanism. Next, we’ll examine how the...

What RPC’s Latest Quarter Tells You RPC (RES) drew fresh attention after second quarter 2026 results outpaced market revenue expectations and the company lifted its capital spending outlook, while also reaffirming a regular quarterly cash dividend. Management pointed to stronger Technical Services performance, improved job mix, and contributions from advanced downhole tools and coiled tubing investments as key supports for the quarter, even as some other service lines softened. See our latest...

HF Sinclair (DINO) is in focus after reporting second quarter results that included higher sales, stronger net income and a 5% dividend increase, along with plans to wind down base oil refining in Mississauga. See our latest analysis for HF Sinclair. HF Sinclair’s share price has gained 26.06% over the past 30 days and 95.24% year to date, with a 124.01% 1-year total shareholder return that points to strong recent momentum rather than a gradual build. If recent earnings and restructuring...

In the second quarter of 2026, Procore Technologies reported revenue of US$375.21 million and net income of US$16.92 million, reversing a loss a year earlier and lifting earnings per share to US$0.11 from a loss per share of US$0.14. For the first half of 2026, Procore moved from a US$54.08 million loss to a US$7.83 million profit while lifting sales to US$734.49 million, and paired this turnaround with revenue guidance of US$382 million–US$384 million for the third quarter and about US$1.51...

In July 2026, Alpha Tau Medical announced that its Alpha DaRT device combined with pembrolizumab produced a 100% objective response rate and a median overall survival of 18.2 months in a small clinical study of elderly patients with locally advanced or metastatic head and neck squamous cell carcinoma, with only mild device-related side effects reported. An interesting aspect of this trial is that it met its pre-set efficacy bar so convincingly that enrollment was stopped early for success...

New US Section 301 tariffs are reshaping global supply chains and changing how cross border costs hit company profit margins. For investors, this is less about headline politics and more about which stocks sit on the right or wrong side of these new trade rules. Some businesses gain breathing room because key imports are exempt. Others face rising input costs and pressure on earnings. This article walks through three stocks that are exposed to the latest tariff moves, with one potentially...

New York Times (NYT) stock closed at US$74.89 on 29 July 2026, drawing attention after recent trading moves and performance figures. Investors are weighing its subscription focused media model and multi year total return record. See our latest analysis for New York Times. The recent pullback to a 1-day share price return of 1.24% lower comes after a 7-day share price return of 4.52% and a year-to-date share price return of 7.26%, while the 1-year total shareholder return of 44.91% points to...

Teradata stock has delivered a 54.1% return over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiple checks still point to the shares trading at a discount to their assessed worth. Over the last 12 months Teradata is up 54.1%, which puts recent momentum in sharp contrast with earlier multi year share price weakness. Teradata’s push into enterprise AI, highlighted by new customer engagements in global financial services, can support expectations...

Mondelez International recently reported second-quarter 2026 results showing higher sales of US$9,355 million and higher net income of US$1,548 million year on year, alongside an ongoing share buyback and a nationwide recall of Cadbury Dairy Milk Oreo Candy bars in the US due to undeclared pistachio allergens. At the same time, the company is using innovation such as cell‑cultured chocolate technology and limited‑edition CHIPS AHOY! Mystery Cookies to respond to cocoa cost volatility and...

In late July 2026, Oracle and Google Cloud expanded their partnership to bring Google's Gemini AI models into Oracle Fusion Applications, NetSuite and the AI Agent Studio, deepening multi-model AI capabilities across Oracle’s enterprise software stack. This collaboration gives Oracle customers and partners broader choice of advanced AI models for building agents and automation, potentially tightening the link between Oracle’s core business applications and next-generation AI tools. Next,...

The Morning Bull - US Market Morning Update Monday, Aug, 3 2026 US stock futures are pointing higher this morning, with S&P 500 contracts up around 0.6%. The move comes as US 10 year Treasury yields hover near 4.7% to 4.8%, which keeps borrowing costs for mortgages, credit cards and corporate debt relatively expensive as the Federal Reserve talks tough on inflation. At the same time, a key consumer confidence survey from Michigan sits at 55.2 for July, a five month high, and one year...

TAL Education Group (NYSE:TAL) has attracted fresh investor attention after reporting first quarter earnings on July 30, 2026, alongside an extension of its share repurchase program through late July 2027. See our latest analysis for TAL Education Group. TAL Education Group's latest earnings release and buyback extension have come alongside strong share price momentum, with a 21.36% 7 day share price return and a 25.00% 30 day share price return. The 5 year total shareholder return of 114.04%...

First National Bank Alaska stock barely flinched after earnings, with the share price essentially flat. This suggests investors saw nothing to force a rethink of the long term thesis. The bank that markets know for steady profitability again reported double digit trailing earnings growth and a net profit margin in the high 30s. That combination keeps the core story intact. The real tension for you as an investor now lies between that earnings power and a stock that trades at a P/E of 12.7x...

AZZ stock performance snapshot AZZ (AZZ) has gained attention after a strong year-to-date move, while recent returns have been more muted. The stock last closed at $144.72, with total revenue of $1.68b and net income of $198.36m. See our latest analysis for AZZ. AZZ’s 1-day share price return slipped 0.17% and the 7-day share price return declined 3.46%. However, the year-to-date share price return of 31.88% and 1-year total shareholder return of 37.04% indicate momentum that has built over a...